Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2007-09-18
2007-09-18
Rao, Deepak (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C544S364000, C544S370000, C546S273400, C548S309700, C548S310100, C548S310400, C548S310700, C548S311700
Reexamination Certificate
active
10273487
ABSTRACT:
2-Aryl substituted benzimidazoles and imidazo[4,5]pyridines are disclosed as inhibitors of Cds1 and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer.
REFERENCES:
patent: 5059621 (1991-10-01), Shroot et al.
patent: 0148431 (1985-07-01), None
patent: 0209707 (1987-01-01), None
patent: 511187 (1992-10-01), None
patent: 0719765 (1996-07-01), None
patent: WO98/06703 (1998-02-01), None
patent: WO99/11627 (1999-03-01), None
patent: WO 99/30710 (1999-06-01), None
patent: WO99/61019 (1999-12-01), None
patent: WO99/61020 (1999-12-01), None
patent: WO 00/26192 (2000-06-01), None
patent: WO 01/00587 (2001-01-01), None
patent: WO 01/53268 (2001-07-01), None
patent: WO 01/74786 (2001-10-01), None
patent: WO 01/98465 (2001-12-01), None
Bartek, DNA Damage Response: Mechanisms and Defects in Human Cancer, Jan. 2004.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Denny et al., Potential Antitumor Agents, Journal of Medicinal Chemistry, vol. 33, No. 2, pp. 814-819, 1990.
Arienti, et al., Checkpoint Kinase Inhibitors; SAR and Radioprotective Properties of a Series of 2-Arylbenzimidazoles, J. Med. Chem., vol. 48, No. 6, pp. 1873-1885, 2005.
Blasina, A. et al. A Human Homologue of the Checkpoint Kinase Cds 1 Directly Inhibits Cdc25 Phosphatase Curr. Biol. (1999) 9(1):1-10.
Buscemi, G. et al. Chk2 Activation Dependence on Nbs1 after DNA Damage Mol. Cell. Biol. (2001) 21(15):5214-5222.
Falck, J. et al. The ATM-Chk2-Cdc25A Checkpoint Pathway Guards against Radioresistant DNA Synthesis Nature (2001) 410:842-847.
Hirao, A. et al. Chk2 is a Tumor Suppressor That Regulates Apoptosis in both an Ataxia Telangiectasia Mutated (ATM)-Dependent and an ATM-Independent Manner Mol. Cell. Biol. (2002) 22(18):6521-6532.
Kim, J.S. et al. Structure-activity Relationships of Benzimidazoles and Related Heterocycles as Topoisomerase I Poisons Bioorg. Med. Chem. (1996) 4(4):621-630.
Lee, J. S. et al. hCds1-Mediated Phosphorylation of BRCA1 Regulates the DNA Damage Response Nature (2000) 404:201-204.
Matsuoka, S. et al. Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase Science (1998) 282:1893-1897.
Takai, H. et al. Chk2-Deficient Mice Exhibit Radioresistance and Defective p53-Mediated Transcription EMBO J. (2002) 21(19):5195-5205.
Tominaga K. et al. Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53 J. Biol. Chem. (1999) 274(44):31463-31467.
White, A.W. et al Resistance-Modifying Agents. 9 Synthesis and Biological Properties of Benzimidazole Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase J. Med. Chem. (2000) 43(22):4084-4097.
Arienti Kristen L.
Axe Frank U.
Breitenbucher J. Guy
Huang Liming
Lee Alice
Harbour John
Ortho-McNeil Pharmaceutical , Inc.
Rao Deepak
LandOfFree
Substituted benzimidazoles and imidazo-[4,5]-pyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzimidazoles and imidazo-[4,5]-pyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzimidazoles and imidazo-[4,5]-pyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3774115